Clinical Trial
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Cancer Type
Leukemia, Myeloma, and Hematologic
Protocol Number
202509144
Principal Investigator
Learn more about this study at
clinicaltrials.gov
For more information contact us here:
Phone
800-600-3606Brief Summary
The purpose of this clinical trial is to compare drug combinations to learn which drugs work best to prevent graft-versus-host-disease (GVHD) in people who have received a stem cell transplant. The source of stem cells is from someone who is not related and has a different blood cell type than the study participant. The researchers will compare the new drug combination to a standard drug combination. They will also learn about the safety of each drug combination.
Participants will:
* Receive the standard or new drug combination after transplant
* Visit the doctor’s office for check-ups and tests after transplant that are routine for most transplant patients
* Take surveys about physical and emotional well-being
* Give blood and stool samples.
Protocol Interventions
Drug: Conditioning Regimen A, Drug: Conditioning Regimen B, Drug: Conditioning Regimen C, Drug: Conditioning Regimen D, Drug: Conditioning Regimen E, Procedure: Hematopoietic Cell Transplantation, Drug: PTCy (25 mg/kg D3, D4), Drug: Post-transplant Tacrolimus, Drug: Post-transplant Mycophenolate mofetil, Drug: Post-transplant Ruxolitinib, Drug: Supportive Care: Growth Factors, Procedure: Supportive Care: Blood Products, Other: Supportive Care: Infection Prophylaxis, Other: Supportive Care: Intravenous immune globulin (IVIG), Drug: Supportive Care: Seizure prophylaxis, Other: Supportive Care: Monitoring and management of CRS, Drug: Supportive Care: Prophylaxis against infections, Other: Supportive Care: Lipid elevations, Other: Study treatment compliance, Other: Prohibited Concomitant Therapy, Other: Permitted Concomitant Therapy
Learn About Clinical Trials
Clinical trials are research studies that help us find new ways to prevent, diagnose, and treat cancer. If you are interested in participating in a clinical trial, our team will help you find a study that is right for you. Call us to speak with a Siteman care coordinator.